Takeda Pharmaceutical Total Liabilities 2010-2024 | TAK

Takeda Pharmaceutical total liabilities for the quarter ending September 30, 2024 were $53.942B, a 6.12% decline year-over-year.

  • Takeda Pharmaceutical total liabilities for 2024 were $54.06B, a 3.92% decline from 2023.
  • Takeda Pharmaceutical total liabilities for 2023 were $56.263B, a 15.65% decline from 2022.
  • Takeda Pharmaceutical total liabilities for 2022 were $66.701B, a 8.26% decline from 2021.

Takeda Pharmaceutical Total Liabilities 2010-2024 | TAK

  • Takeda Pharmaceutical total liabilities for 2024 were $54.06B, a 3.92% decline from 2023.
  • Takeda Pharmaceutical total liabilities for 2023 were $56.263B, a 15.65% decline from 2022.
  • Takeda Pharmaceutical total liabilities for 2022 were $66.701B, a 8.26% decline from 2021.